Paragraphs
 

STRONG ACCURACY AND OUTCOMES ACROSS ALL MAJOR INDICATORS

 
Selector Id
strong-accuracy
Selector Class
impact-control
mard

A demonstrated 8.5% Mean Absolute Relative Difference (MARD)¹

adherence

Sensor adherence of +23hrs per day4,5

technology

Fluorescence-based technology unaffected by ascorbic acid and acetaminophen²

A1C

A clinically meaningful A1C reduction across major studies1,6,7

accuracy

Exceptional accuracy in the 40-60 mg/dL hypoglycemic range (86.5% within 15/15 YSI)³

time in range

Exceptional real-world time in target1

EXCEPTIONAL PERFORMANCE AND REAL-WORLD OUTCOMES

 
two women

A1C Reduction

Overall A1C level

Precise

0.4%

From a baseline of 7.5%

Precise II

0.5%

From a baseline of 7.6%

Precision

0.3%

From a baseline of 7.8%

MARD

Overall %

11.1%

8.5%

9.6%

Adherence

Hours per day

+23.0

+23.4

+23.2

Time in target

Overall %

+59.9%

+57.6%

+59.0%

hypoglycemic detection

Overall %

70 mg/dl

81%

70 mg/dl

93%

70 mg/dl

95%

A1C Reduction

Overall A1C level

Precise

0.4%

From a baseline of 7.5%

MARD

Overall %

11.1%

Adherence

Hours per day

+23.0

Time in target

Overall %

+59.9%

hypoglycemic detection

Overall %

70 mg/dl

81%

A1C Reduction

Overall A1C level

Precise II

0.5%

From a baseline of 7.6%

MARD

Overall %

8.5%

Adherence

Hours per day

+23.4

Time in target

Overall %

+57.6%

hypoglycemic detection

Overall %

70 mg/dl

93%

A1C Reduction

Overall A1C level

Precise

0.3%

From a baseline of 7.8%

MARD

Overall %

9.6%

Adherence

Hours per day

+23.2

Time in target

Overall %

+59.0%

hypoglycemic detection

Overall %

70 mg/dl

95%

For more information on Eversense’s safety and performance, download
our Performance and Outcomes
Data Sheet.

Selector Class
product-sheet x-overflow
Selector Class
section-next
Selector Class
section-lists
Sub Description

The advanced sensor technology and under-the-skin placement help patients reach unprecedented levels of wear time, leading to improved clinical outcomes.